000 01524 a2200445 4500
005 20250513220826.0
264 0 _c20001030
008 200010s 0 0 eng d
022 _a1098-1004
024 7 _a10.1002/1098-1004(200009)16:3<270::AID-HUMU14>3.0.CO;2-J
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKoizumi, A
245 0 0 _aA cluster of lysinuric protein intolerance (LPI) patients in a northern part of Iwate, Japan due to a founder effect. The Mass Screening Group.
_h[electronic resource]
260 _bHuman mutation
_cSep 2000
300 _a270-1 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmino Acid Metabolism, Inborn Errors
_xepidemiology
650 0 4 _aAmino Acids, Diamino
_xmetabolism
650 0 4 _aCarrier Proteins
_xgenetics
650 0 4 _aFounder Effect
650 0 4 _aGenetic Carrier Screening
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aJapan
_xepidemiology
650 0 4 _aLysine
_xmetabolism
650 0 4 _aPedigree
700 1 _aShoji, Y
700 1 _aNozaki, J
700 1 _aNoguchi, A
700 1 _aE, X
700 1 _aDakeishi, M
700 1 _aOhura, T
700 1 _aTsuyoshi, K
700 1 _aYasuhiko, W
700 1 _aManabe, M
700 1 _aTakasago, Y
700 1 _aTakada, G
773 0 _tHuman mutation
_gvol. 16
_gno. 3
_gp. 270-1
856 4 0 _uhttps://doi.org/10.1002/1098-1004(200009)16:3<270::AID-HUMU14>3.0.CO;2-J
_zAvailable from publisher's website
999 _c10927810
_d10927810